Papers
6
Total Citations
110
H-Index
4
About
Dr. Lin Cai is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive kidney surgery, with a particular focus on robot-assisted partial nephrectomy and novel surgical technologies. Her most significant contribution is leading the first double-center prospective randomized controlled noninferiority trial comparing the newly developed KangDuo surgical robot (KD-SR) against the da Vinci Si system for partial nephrectomy, a landmark study published in 2022 that has already garnered 54 citations. This work, alongside her 2021 study on retroperitoneal partial nephrectomy with the KD-SR-01 system (25 citations), has been instrumental in validating Chinese-made robotic platforms for complex renal procedures. Dr. Cai has also advanced surgical technique through comparative analyses of robot-assisted versus conventional laparoscopic ileal ureter replacement (19 citations) and developed innovative preoperative evaluation tools, including the three-dimensional ADDD nephrometry system (2023) and extended renal tumor plane technique (2024). Her research directly impacts surgical planning and outcomes, demonstrating that new robotic systems can achieve noninferior results to established platforms while potentially expanding access to minimally invasive surgery. With over 110 total citations and a growing portfolio of high-impact studies, Dr. Cai is establishing herself as a leading voice in the global transition toward more accessible, technology-driven urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6